BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 31, 2014
View Archived Issues
Activase given orphan drug status in U.S. for plastic bronchitis
Read More
Qiagen to develop companion diagnostics for Astellas drugs
Read More
MUSK gene associated with FADS and identified as a potential target for the disease
Read More
Pfizer offers overview of third quarter 2014
Read More
Polyphor presents new antibacterial beta-hairpin peptidomimetics
Read More
University of California at Oakland reports new gamma-secretase modulators
Read More
New compounds for tuberculosis reported by U.S. academics
Read More
Pipeline progress at Mitsubishi Tanabe Pharma during second quarter of fiscal 2014
Read More
3B Pharmaceuticals presents a novel NTR1 antagonist for imaging and targeted radiotherapy
Read More
Discovery of a novel drug target and new pharmacological agents to treat multiple myeloma
Read More
T-cell immunotherapy ATIR receives EMA orphan status for acute myeloid leukemia
Read More
Orion Pharma begins phase I study of ODM-203 in advanced solid tumors
Read More
Celgene to begin phase II study of PDA-002
Read More
KRN-23 granted orphan drug status in Europe for X-linked hypophosphatemia
Read More
Researchers discover new gene mutation implicated in salivary gland cancer
Read More
Bayer Yakuhin seeks to expand Ciproxan indications in Japan
Read More
Mutations in the TENM4 gene are associated with essential tremor
Read More
FDA grants breakthrough therapy designation to NBI-98854 for tardive dyskinesia
Read More
Critical Outcome Technologies advances pre-IND testing of COTI-2
Read More
FDA advisory committee recommends approval of Savaysa for stroke prevention in atrial fibrillation
Read More
Onxeo reports data from phase II trial of Validive for prevention of severe oral mucositis
Read More
AnaMar reports topline data from phase IIa study of AMAP-102
Read More
Auspex initiates second pivotal study of SD-809 for tardive dyskinesia
Read More
Paratek Pharmaceuticals and Transcept Pharmaceuticals complete merger
Read More
University of Michigan patents new dual MEK/PI3K inhibitors
Read More
Janssen Pharmaceutica presents new PERK inhibitors
Read More